(Q36504830)

English

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

scientific article published on May 2006

In more languages
default values for all languages
No label defined

No description defined

Statements

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit